US Stock MarketDetailed Quotes

OSTX OS Therapies

Watchlist
  • 3.670
  • +1.170+46.80%
Close Dec 11 16:00 ET
  • 3.640
  • -0.030-0.82%
Post 19:36 ET
77.94MMarket Cap-10.49P/E (TTM)

About OS Therapies Company

OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.

Company Profile

SymbolOSTX
Company NameOS Therapies
Listing DateAug 1, 2024
Issue Price4.00
Founded2018
CEOMr. Paul A. Romness, M.P.H.
MarketAMEX
Employees4
Fiscal Year Ends12-31
Address15825 Shady Grove Road,Suite 135
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-410-297-7793
Websitehttp://www.ostherapies.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul A. Romness, M.P.H.
  • President, Chief Executive Officer and Director
  • 360.00K
  • Christopher P. Acevedo
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Gerald E. Commissiong
  • Chief Business Officer
  • --
  • Dr. Robert G. Petit, PhD
  • Chief Medical Officer and Chief Scientific Officer
  • 360.00K
  • John Ciccio
  • Independent Director
  • 40.00
  • Avril McKean Dieser, J.D.,M.A.
  • Independent Director
  • --
  • Dr. Theodore F. Search, Pharm.D.,R.Ph.
  • Independent Director
  • 40.00
  • Olivier R. Jarry, M.B.A.,M.S.
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+1.11%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-8.50%